-
Mashup Score: 1#NephMadness 2022: Nephropath Region - 3 year(s) ago
Submit your picks! | NephMadness 2022 | #NephMadness | #Nephropath Selection Committee Member: Shree Sharma @nephrosharma Shree Sharma is the Laboratory Director at Arkana Laboratories in Little Ro…
Source: AJKD BlogCategories: Latest Headlines, NephrologyTweet
-
Mashup Score: 0#NephMadness 2022: Nephropath Region - 3 year(s) ago
Submit your picks! | NephMadness 2022 | #NephMadness | #Nephropath Selection Committee Member: Shree Sharma @nephrosharma Shree Sharma is the Laboratory Director at Arkana Laboratories in Little Ro…
Source: AJKD BlogCategories: Latest Headlines, NephrologyTweet-
@Elena_Cervants @nephrosharma @Maximal_Change @Khairallah_P PLA2R is a superstar and has been hogging the spotlight for years. Consequently, we’ve neglected the cadre of up and coming players in the membranous antigen world - learn about the “newer” antigens here: https://t.co/X1G01xvNd2 #NephMadness #Nephropath https://t.co/Fn0xHps1Fj
-
-
Mashup Score: 0#NephMadness 2022: Nephropath Region - 3 year(s) ago
Submit your picks! | NephMadness 2022 | #NephMadness | #Nephropath Selection Committee Member: Shree Sharma @nephrosharma Shree Sharma is the Laboratory Director at Arkana Laboratories in Little Ro…
Source: AJKD BlogCategories: Latest Headlines, NephrologyTweet-
@Elena_Cervants @nephrosharma @Maximal_Change @Khairallah_P PLA2R has been the membranous king for over a decade now. Its use in the diagnosis, prognosis, and treatment of disease has been studied and validated over and over again. https://t.co/RFmx6ckU0K #NephMadness #Nephropath https://t.co/LpsOywW2Cg
-
-
Mashup Score: 5#NephMadness 2022: Nephropath Region - 3 year(s) ago
Submit your picks! | NephMadness 2022 | #NephMadness | #Nephropath Selection Committee Member: Shree Sharma @nephrosharma Shree Sharma is the Laboratory Director at Arkana Laboratories in Little Ro…
Source: AJKD BlogCategories: Latest Headlines, NephrologyTweet-
Competitors for the #NephropathRegion 🥊 PLA2R vs Other MN Antigens 🥊 DNAJB9 vs. IgG4 The scouting report 👉 https://t.co/pB4hSv9QaW by @elena_cervants @nephrosharma #NephJC #NephMadness
-
-
Mashup Score: 0#NephMadness 2022: Nephropath Region - 3 year(s) ago
Submit your picks! | NephMadness 2022 | #NephMadness | #Nephropath Selection Committee Member: Shree Sharma @nephrosharma Shree Sharma is the Laboratory Director at Arkana Laboratories in Little Ro…
Source: AJKD BlogCategories: Latest Headlines, NephrologyTweet-
The first matchup in the #Nephropath region pits superstar PLA2R against all other antigens, with the second matchup focused on DNAJB9 vs IgG4. Plus, plenty of path pics! https://t.co/8tjs2gBDaB @Elena_Cervants @nephrosharma @Maximal_Change @Khairallah_P #NephMadness https://t.co/4eNbsK0p0L
-
-
Mashup Score: 0#NephMadness 2022: Nephropath Region - 3 year(s) ago
Submit your picks! | NephMadness 2022 | #NephMadness | #Nephropath Selection Committee Member: Shree Sharma @nephrosharma Shree Sharma is the Laboratory Director at Arkana Laboratories in Little Ro…
Source: AJKD BlogCategories: Latest Headlines, NephrologyTweet-
#NephMadness 2022: Nephropath Region @nephrosharma @Elena_Cervants @Maximal_Change @Khairallah_P #Nephropath https://t.co/LY9tDEzeHf
-
-
Mashup Score: 1Clinical Approach to a Patient With an Acid-Base Disturbance - 3 year(s) ago
A 65-year-old woman with a medical history of diabetes mellitus, obesity, compensated cirrhosis, and nonalcoholic steatohepatitis had right first distal phalanx osteomyelitis diagnosed 4 weeks before presentation and underwent right below-knee amputation. She was admitted to the hospital with abdominal pain and hematemesis.
Categories: Latest Headlines, NephrologyTweet-
#Quiz from the AJKD archive (Feb 2021) Clinical Approach to a Patient With an Acid-Base Disturbance https://t.co/2DJ2dRkkS7 (FREE) @Elena_Cervants @StevenMenez @MoHanouneh https://t.co/VqljYf8Aj2
-
-
Mashup Score: 3#NephJC Healthcare Social Media Analytics - 3 year(s) ago
Top Influencers of the #NephJC healthcare social media hashtag.
Source: SymplurCategories: Latest Headlines, NephrologyTweet-
Excellent participation overall The numbers: 711 Tweets. 144 Participants. 6,375,582 Impressions. February 8 and 9 2022. More #NephJC 📊 here https://t.co/eFSFYTSlN8 via @symplur great job @michaelturk6 @divyaa24 @Elena_Cervants https://t.co/JpnzZJRRDc
-
-
Mashup Score: 3Timing Dialysis Right: The Visual Abstract — NephJC - 3 year(s) ago
Created in a time crunch, the visual abstract for this week’s study from Elena Cervantes:
Source: NephJCCategories: Latest Headlines, NephrologyTweet-
And the VA from NSMC’s very own @Elena_Cervants https://t.co/gQNIZaL29u #NephJC
-
-
Mashup Score: 6Advocating for Patients with Vasculitis: A Steroid-Sparing Regimen with Avacopan — NephJC - 3 year(s) ago
This week, we will discuss the ADVOCATE trial. Avacopan is not just a flash in the pan? We hope so, having won the RheumMadness and offering a steroid free hope.
Source: NephJCCategories: Latest Headlines, NephrologyTweet-
Check out the #NephJC coverage from @drkeia @Elena_Cervants @alunieczka https://t.co/i02spOijpL with @Deep_Phachu VA of the ADVOCATE trial that drove this approval https://t.co/7TmYmXGCE4
-
Though PLA2R is the king - the trendsetting and biggest player, one wonders if the disease-antigen associations may win the game? See the scouting report from @Elena_Cervants https://t.co/BGo3O54aj0 #NephroPathRegion #NephMadness